Syncona is a FTSE 250 healthcare company focused on creating global leaders in life sciences. We operate as a hands-on venture capital, working closely with world class scientists to found, build and scale companies with the aim of delivering transformational treatments to patients. We invest in all therapeutic modalities (e.g., small molecules, antibodies, nucleic acid therapies) and currently have 11 companies in our portfolio that are developing therapies to treat diseases such as cancer, neurological disorders, metabolic disorders and inherited diseases. In parallel to supporting our portfolio companies, we are also constantly looking for the next breakthroughs in science and medicine and remain actively engaged with the academic and clinician communities.
Overview
Syncona are offering one PhD scholarship available to students conducting their doctoral research within Life Sciences at an accredited UK university. The scholarships are aimed at those from a Black African, Black Caribbean or Mixed Black heritage to support diversifying the talent pipeline in the sector.
Find out more and apply online.
